FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/14/2023
Back to search
Official data from USPTO
CRISPR-Q
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
02/14/2023
Trademark type
Word
Nice classes
1, 5
Filing date
06/18/2021
Registration date
09/27/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/27/2022
Last transaction
09/27/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
DE
Examiner
GULIANO, ROBERT N
Law office
L50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Qiagen GmbH
Representatives
Randolph E. Digges, III Rankin, Hill & Clark LLP
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicalbiochemical and biotechnological diagnostic preparations for scientific use; non-medical reagents used in analytical chemistryfor scientific and/or medical research use for markingseparatingisolatingamplifyingcloningsequencing and/or for the analysis of biopolymers in the nature of nucleic acidsin particular reagentsenzymes and buffer solutions for isolatingamplifying and analysing nucleic acids; chemical test kits for laboratory or research use for markingseparatingisolatingamplifyingcloningsequencing and/or for the analysis of biopolymers in the nature of nucleic acidsin particular comprising reagentsenzymes and buffer solutions for isolatingamplifying and analysing nucleic acids
Class 5
Diagnostic preparations for medical and veterinary purposesdiagnostic preparations for markingseparatingisolatingamplifyingcloningsequencing and/or for the analysis of biopolymers in the nature of acids; diagnostic reagentsenzymes and buffer solutions for isolatingamplifying and analysing nucleic acids for medical or veterinary purposes; chemicalbiochemical and biotechnological diagnostic preparations for medical and veterinary purposesreagentsenzymes and buffer solutions for markingseparatingisolatingamplifyingcloningsequencing and/or for the analysis of biopolymers in the nature of nucleic acids; diagnostic kits containing preparations for medical and veterinary diagnostic purposespreparations for markingseparatingisolatingamplifyingcloningsequencing and/or for the analysis of biopolymers in the nature of nucleic acids; diagnostic kits containing reagentsenzymes and buffer solutions for isolatingamplifying and analysing nucleic acids for medical or veterinary purposes
Publications
History of USPTO decisions and trademark events.
25 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/25/2023
FIMP
FINAL DISPOSITION PROCESSED
01/25/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/27/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/27/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
09/27/2022
GPNX
NOTIFICATION PROCESSED BY IB
07/19/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/12/2022
PUBO
PUBLISHED FOR OPPOSITION
07/12/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/29/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/29/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/22/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/09/2022
RFNT
REFUSAL PROCESSED BY IB
05/16/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/12/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/12/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/12/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/26/2022
RFRR
REFUSAL PROCESSED BY MPU
04/26/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/16/2022
CNRT
NON-FINAL ACTION WRITTEN
03/15/2022
DOCK
ASSIGNED TO EXAMINER
03/10/2022
MAFR
APPLICATION FILING RECEIPT MAILED
12/03/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/29/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/25/2021
Continuous trademark protection
Get notified about every new filing that threatens CRISPR-Q or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.